You are currently viewing US FDA approves first drug for fatty liver disease NASH

US FDA approves first drug for fatty liver disease NASH



Reuters was first to report on the FDA approving Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug to treat a fatty liver disease known as non-alcoholic steatohepatitis (NASH). The approval was the first of its kind. 

Market Impact

The company’s shares surged 24% in extended trading.

Article Tags

Topics of Interest: Health

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Americas

Countries: United States

Win Types: Speed

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

Source link

Gadget Explorer Pro

Gadget Explorer Pro is an expert writer specializing in comprehensive reviews, insightful articles, and detailed comparisons of consumer electronics. With a passion for technology and years of experience, they offer unbiased analysis of the latest gadgets, from cameras to smart home devices. Known for making complex tech understandable, Gadget Explorer Pro helps readers make informed decisions. Follow them for expert advice and the latest trends in the world of technology.

Leave a Reply